These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11499962)

  • 1. Quality and risk management: the commitment of the Council of Europe.
    Bopp KF
    Transfus Clin Biol; 2001 Jun; 8(3):218-9. PubMed ID: 11499962
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of improved safety on maintaining a sufficient blood supply.
    Reynolds E; Wickenden C; Oliver A
    Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs?
    Dodd RY; Sullivan MT
    Transfusion; 1998 Mar; 38(3):221-3. PubMed ID: 9563399
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood safety and Creutzfeldt-Jakob disease.
    Wkly Epidemiol Rec; 1998 Jan 2-9; 73(1-2):6-7. PubMed ID: 9448481
    [No Abstract]   [Full Text] [Related]  

  • 7. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 8. Making blood safer.
    Mortimer PP
    BMJ; 2002 Aug; 325(7361):400-1. PubMed ID: 12193340
    [No Abstract]   [Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 11. Prions and blood transfusion.
    Barbara J
    Transfus Sci; 2000; 22(1-2):49. PubMed ID: 10771380
    [No Abstract]   [Full Text] [Related]  

  • 12. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products.
    Prowse C; Cuthbertson B; Turner M
    Haemophilia; 2011 Jul; 17(4):703. PubMed ID: 21362112
    [No Abstract]   [Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease and blood products: FDA policy.
    Fratantoni JC
    Biologicals; 1998 Jun; 26(2):133-4. PubMed ID: 9811520
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood system changes since recognition of transfusion-associated AIDS.
    Epstein JS; Jaffe HW; Alter HJ; Klein HG
    Transfusion; 2013 Oct; 53(10 Pt 2):2365-74. PubMed ID: 24032622
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal leucodepletion--practical and regulatory consequences.
    Barrowcliffe TW
    Transfus Sci; 1998 Dec; 19(4):361. PubMed ID: 10351156
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemovigilance in the United Kingdom and Europe.
    Stainsby D
    Hematol J; 2004; 5 Suppl 3():S175-8. PubMed ID: 15190303
    [No Abstract]   [Full Text] [Related]  

  • 18. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 19. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 20. [Informing the transfused patient of the possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion].
    Boixière A; Hergon E; Duchange N; Bellier L; Moutel G; Rouger P; Hervé C
    Presse Med; 2004 Dec; 33(21):1533-7. PubMed ID: 15637795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.